Director, SEC Reporting & Technical Accounting jobs in United States
cer-icon
Apply on Employer Site
company-logo

MicroTransponder · 2 months ago

Director, SEC Reporting & Technical Accounting

MicroTransponder, Inc. is dedicated to transforming the lives of stroke survivors through its innovative neurostimulation technology. The Director of SEC Reporting & Technical Accounting will lead all aspects of technical accounting and SEC reporting, ensuring compliance with regulatory standards and preparing accurate financial reports and disclosures.

Health CareMedicalMedical DeviceNeuroscience

Responsibilities

SEC Filings: Direct the preparation and submission of all periodic SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and other required filings, ensuring full compliance with regulatory requirements
Coordinate with external auditors, legal counsel, and other stakeholders on filings
Support the preparation of materials for the audit committee and investor relations
Technical Accounting: Stay ahead of changes in accounting standards and SEC regulations, draft technical memos, and provide executive guidance on their impact to financial reporting and disclosures
Research and interpret complex technical accounting topics (e.g., revenue recognition, stock-based compensation, leases, business combinations) according to U.S. GAAP
Write technical accounting memos to document and support the company's accounting positions
Assess the impact of new accounting standards and lead implementation efforts
Review and approve the accounting for complex transactions
Financial Statements: Oversee the preparation of financial statements, footnotes, and disclosures for SEC filings, ensuring accuracy and compliance with U.S. GAAP and SEC regulations
Financial Analysis: Review and analyze financial data for accuracy and completeness, identifying issues and driving process improvements
Internal Controls: Establish and maintain strong internal controls around SEC reporting to protect the integrity and accuracy of financial information
Cross-Functional Collaboration: Partner with finance, legal, operations, and external auditors to gather inputs and support timely SEC reporting
Disclosure Committee: Lead or actively participate in disclosure committee meetings to review and approve financial disclosures, ensuring accuracy and consistency
SOX Compliance: Oversee the assessment, testing, and documentation of internal controls related to financial reporting (SOX compliance)
Stock-Based Compensation: Provide leadership and accounting oversight for stock-based compensation arrangements
Filing Calendar: Manage the SEC reporting calendar, ensuring all filing deadlines are met and proactively communicating risks or potential delays

Qualification

CPAU.S. GAAPSEC reportingTechnical accountingFinancial systemsSarbanes-Oxley ActAnalytical skillsLeadershipCommunicationDetail-oriented

Required

Bachelor's degree in Accounting or related field required
CPA required
7–10 years of progressive accounting and reporting experience, including at least 5 years in public accounting
2+ years of direct financial reporting and SEC reporting experience
Demonstrated expertise with 10-K and 10-Q filings across multiple entities
Deep knowledge of U.S. GAAP, SEC regulations, and technical accounting
Strong analytical and executive-level technical accounting skills
Exceptional communication, leadership, and interpersonal abilities
Highly detail-oriented with proven ability to manage multiple priorities
Ability to thrive in a fast-paced, deadline-driven environment
Proficiency in financial systems and reporting tools
Solid knowledge of Sarbanes-Oxley Act (SOX) compliance

Preferred

Masters degree preferred
S-1 and IPO experience strongly preferred

Benefits

Medical, dental and vision plans along with an FSA
401(k) plan with company matching
Unlimited Paid Time Off (PTO) program
Approximately 18 paid company holidays per year

Company

MicroTransponder

twittertwitter
company-logo
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Funding

Current Stage
Late Stage
Total Funding
$180.12M
Key Investors
U.S. Venture PartnersMedTech InnovatorGreen Park & Golf Ventures
2025-03-12Series F· $65M
2023-06-06Non Equity Assistance
2022-06-20Series E· $73M

Leadership Team

leader-logo
Richard Foust
Chief Executive Officer
linkedin
leader-logo
Bunker Curnes
Chief Financial Officer
linkedin
Company data provided by crunchbase